Endothelium-targeted transgenic GTP-cyclohydrolase I overexpression inhibits neointima formation in mouse carotid artery

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 12, 2007, Pages 1260-1266

  Liao, Song Jie ^a,b   Lin, Li ^a   Zeng, Jin Sheng ^a,b   Huang, Ru Xun ^a,b   Channon, Keith M ^a,c   Chen, Alex F ^a,d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Carotid artery; Endothelial nitric oxide synthase; GTP cyclohydrolase I; Restenosis; Tetrahydrobiopterin (BH4)

Indexed keywords

EVANS BLUE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TETRAHYDROBIOPTERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY OBSTRUCTION; CELL STRUCTURE; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTROPHY; IN VIVO STUDY; INTIMA; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; RELAXATION TRAINING; STAINING;

ANIMALS; AORTA; BIOPTERIN; CAROTID ARTERIES; CORONARY RESTENOSIS; GTP CYCLOHYDROLASE; HYPERTROPHY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NITRIC OXIDE; TUNICA INTIMA;

EID: 35548947086     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04719.x     Document Type: Article

References (54)

1. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J. Intern. Med. 1994 236 : 567 73.
2. Tsivgoulis G, Vemmos K, Papamichael C et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006 37 : 1913 16.
3. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007 115 : 459 67.
4. Serruys PW, Luijten HE, Beatt KJ et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988 77 : 361 71.
5. Sonmez K, Turan F, Gencbay M, Degertekin M, Duran NE. Long-term (> 3 years) clinical and angiographic outcomes of coronary multilink stent implantations: A single center experience. Angiology 2004 55 : 469 77.
6. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001 104 : 2673 8.
7. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000 101 : 1899 906.
8. Baek SH, Hrabie JA, Keefer LK et al. Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 2002 105 : 2779 84.
9. Lin CE, Garvey DS, Janero DR et al. Combination of paclitaxel and nitric oxide as a novel treatment for the reduction of restenosis. J. Med. Chem. 2004 47 : 2276 82.
10. Janssens S, Flaherty D, Nong Z et al. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 1998 97 : 1274 81.
11. von der Thusen JH, Fekkes ML, Passier R et al. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 357 62.
12. Yogo K, Shimokawa H, Funakoshi H et al. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler. Thromb. Vasc. Biol. 2000 20 : E96 100.
13. Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2006 26 : 2439 44.
14. Vasquez-Vivar J, Kalyanaraman B, Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: Enzymology and physiological implications. Free Radic. Res. 2003 37 : 121 7.
15. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 413 20.
16. Landmesser U, Dikalov S, Price SR et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003 111 : 1201 9.
17. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001 38 : 1044 8.
18. Shinozaki K, Nishio Y, Okamura T et al. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res. 2000 87 : 566 73.
19. Zheng JS, Yang XQ, Lookingland KJ et al. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 2003 108 : 1238 45.
20. Wang CH, Li SH, Weisel RD et al. Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005 289 : R299 304.
21. Alp NJ, Mussa S, Khoo J et al. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J. Clin. Invest. 2003 112 : 725 35.
22. Ii M, Takenaka H, Asai J et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res. 2006 98 : 697 704.
23. Liehn EA, Schober A, Weber C. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 1891 6.
24. Gunnett CA, Heistad DD, Faraci FM. Gene-targeted mice reveal a critical role for inducible nitric oxide synthase in vascular dysfunction during diabetes. Stroke 2003 34 : 2970 4.
25. Miller AL, Plane F, Jeremy JY, McKinnon HJ, Jackson CL. Delayed recovery of receptor-mediated functional responses to acetylcholine in mouse isolated carotid arteries following endothelial denudation in vivo. J. Vasc. Res. 2003 40 : 449 59.
26. Mukai Y, Rikitake Y, Shiojima I et al. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J. Clin. Invest 2006 116 : 334 43.
27. Ohashi Y, Kawashima S, Hirata K et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J. Clin. Invest. 1998 102 : 2061 71.
28. Schober A, Zernecke A, Liehn EA et al. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ. Res. 2004 95 : 1125 33.
29. Zernecke A, Liehn EA, Fraemohs L et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 2006 26 : E10 13.
30. Fournet-Bourguignon MP, Castedo-Delrieu M, Bidouard JP et al. Phenotypic and functional changes in regenerated porcine coronary endothelial cells: Increased uptake of modified LDL and reduced production of. Circ. Res. 2000 86 : 854 61.
31. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 445 50.
32. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 1996 78 : 225 30.
33. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989 83 : 1774 7.
34. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 1994 267 : C1405 13.
35. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 1995 76 : 980 6.
36. Tomita H, Egashira K, Kubo-Inoue M et al. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler. Thromb. Vasc. Biol. 1998 18 : 1456 64.
37. Trachtman H, Futterweit S, Garg P, Reddy K, Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 1996 218 : 704 8.
38. Carretero OA. Vascular remodeling and the kallikrein-kinin system. J. Clin. Invest. 2005 115 : 588 91.
39. Moore ZW, Hui DY. Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase. J. Lipid Res. 2005 46 : 2083 90.
40. Iwakura A, Luedemann C, Shastry S et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003 108 : 3115 21.
41. Ozaki M, Kawashima S, Yamashita T et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 2002 110 : 331 40.
42. Zhang LN, Wilson DW, da Cunha V et al. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler. Thromb. Vasc. Biol. 2006 26 : 765 72.
43. Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 2002 8 : 403 9.
44. Xu Y, Arai H, Zhuge X et al. Role of bone marrow-derived progenitor cells in cuff-induced vascular injury in mice. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 477 82.
45. Shiba Y, Takahashi M, Yoshioka T et al. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: The critical role of the SDF-1-CXCR4 system. Arterioscler. Thromb. Vasc. Biol. 2007 27 : 283 9.
46. d'Uscio LV, Katusic ZS. Increased vascular biosynthesis of tetrahydrobiopterin in apolipoprotein E-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2006 290 : H2466 71.
47. Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney Jr. JF. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ. Res. 2005 96 : 164 71.
48. Katusic ZS, Stelter A, Milstien S. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1998 18 : 27 32.
49. Souza HP, Souza LC, Anastacio VM et al. Vascular oxidant stress early after balloon injury: Evidence for increased NAD(P)H oxidoreductase activity. Free Radic. Biol. Med. 2000 28 : 1232 42.
50. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. Circ. Res. 1999 84 : 113 21.
51. Szocs K, Lassegue B, Sorescu D et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 2002 22 : 21 7.
52. Beller CJ, Radovits T, Kosse J, Gero D, Szabo C, Szabo G. Activation of the peroxynitrite-poly (adenosine diphosphate-ribose) polymerase pathway during neointima proliferation: A new target to prevent restenosis after endarterectomy. J. Vasc. Surg. 2006 43 : 824 30.
53. Stone GW, Moses JW, Ellis SG et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med. 2007 356 : 998 1008.
54. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 2007 356 : 1009 19.